...
机译:具有预防丙二醇和静脉肝素或前列腺素的成年人同种异体造血细胞移植后异种造血细胞移植后肝静脉闭塞疾病/正弦梗阻综合征的发病率及危险因素
Catholic Univ Korea Dept Hematol Catholic Hematol Hosp Seoul South Korea;
Catholic Univ Korea Dept Hematol Catholic Hematol Hosp Seoul South Korea;
Catholic Univ Korea Dept Hematol Catholic Hematol Hosp Seoul South Korea;
Catholic Univ Korea Dept Hematol Catholic Hematol Hosp Seoul South Korea;
Catholic Univ Korea Dept Hematol Catholic Hematol Hosp Seoul South Korea;
Catholic Univ Korea Dept Hematol Catholic Hematol Hosp Seoul South Korea;
Catholic Univ Korea Dept Hematol Catholic Hematol Hosp Seoul South Korea;
Catholic Univ Korea Dept Hematol Catholic Hematol Hosp Seoul South Korea;
Catholic Univ Korea Dept Hematol Catholic Hematol Hosp Seoul South Korea;
Catholic Univ Korea Dept Hematol Catholic Hematol Hosp Seoul South Korea;
Catholic Univ Korea Dept Hematol Catholic Hematol Hosp Seoul South Korea;
Catholic Univ Korea Dept Hematol Catholic Hematol Hosp Seoul South Korea;
Catholic Univ Korea Dept Hematol Catholic Hematol Hosp Seoul South Korea;
Catholic Univ Korea Dept Hematol Catholic Hematol Hosp Seoul South Korea;
机译:接受造血干细胞移植的小儿患者肝静脉闭塞性疾病的发生率较低,这归因于在单个移植机构中静脉注射肝素,口服谷氨酰胺和熊糖二醇的组合。
机译:预防性小剂量肝素或前列腺素E1可以预防韩国儿童同种异体造血干细胞移植后严重的肝静脉闭塞性疾病
机译:None
机译:与经历同种异体造血干细胞移植的青少年和青少年较差的预移植危险因素
机译:预防性小剂量肝素或前列腺素E1可以预防韩国儿童异基因造血干细胞移植后严重的肝静脉闭塞性疾病
机译:预防性小剂量肝素或前列腺素E1可以预防韩国儿童异基因造血干细胞移植后严重的肝静脉闭塞性疾病